InvestorWire NewsRoom

Article

United Medical Equipment Business Solutions Network Inc. Stands Ready to Address Swelling Market Need
February 16, 2021

United Medical Equipment Business Solutions Network Inc. Stands Ready to Address Swelling Market Need

  • Frequent, COVID-19 rapid tests could spur end of pandemic, make stay-at-home orders possible
  • Countries turning to faster, more affordable tests to curb virus spread, enable economic recovery
  • United Medical poised to capitalize on surging demand for rapid testing

Frequent rapid testing could curb COVID-19 within weeks, a recent study published by the University of Colorado Boulder and Harvard University shows (https://ibn.fm/qmy42). Factors such as test turnaround-time and frequency are key in limiting the spread of the virus, making rapid tests one of the key tools for managing the virus outbreak. As such, the rapid tests are increasingly used in countries around the world to enable economic revival and help societies go back to normal. United Medical Equipment Business Solutions Network (“UME”), a company offering both antigen and antibody rapid COVID-19 test kits, stands ready to respond to the growing need for this critical public health tool.

The study demonstrates that testing half of the population weekly with inexpensive, rapid-turnaround COVID-19 tests could accelerate virus elimination within weeks. Despite their lower sensitivity compared to gold-standard clinical tests, these rapid kits could enable an approach based on “personalized stay-at-home orders,” which would remove the need for mass closures of hospitality outlets, retail stores and schools, the study notes. For example, in a hypothetical scenario involving a city with 4% of individuals already infected, rapid testing three out of four people every three days would reduce the number ultimately infected by as much as 88%. This would be sufficient to push the epidemic toward extinction within six weeks, authors claim.

The research was published against the backdrop of significant commercial and academic effort to develop low-cost, rapid tests that could be deployed in large public settings or commercialized for do-it-yourself use. These tests could enable the comeback of public events, such as sports competitions, concerts and travel, which are currently almost completely shut down because of their high risk of virus spread. Combined with the use of masks, rapid testing of people involved in these activities could bring back to life almost-decimated sectors while minimizing the spread risk at the same time.

Several countries have already begun countrywide testing, while the new U.S. administration has named rapid testing as a priority. As the countries are turning to faster, cheaper tests to accelerate the COVID-19 public health response, demand for these products is growing. As a supplier of rapid COVID-19 test kits, United Medical is poised to capitalize on the surging need for rapid testing. Designed to test workers without symptoms as well as those who show certain symptoms or have been in close contact with someone who has been infected, these test kits could be the answer to large-scale testing needs in the future. Capable of quickly and affordably identifying individuals who are most likely to be actively infectious, these products will continue to be a valuable addition to the tool kit in the fight against COVID-19. Testing is most likely to remain an important part of health protocols even after the widespread rollout of the vaccines, securing the sizeable market for rapid testing kits in the future.

For more information about United Medical as well as its Medication Management app, visit the www.UnitedMedSolutions.com and www.MedicationManagement.app.

NOTE TO INVESTORS: The latest news and updates relating to United Medical Equipment are available in the company’s newsroom at https://ibn.fm/UnitedMed

About InvestorWire

InvestorWire is the wire service that gives you more. From regional releases to global announcements presented in multiple languages, we offer the wire-grade dissemination products you’ll need to ensure that your next press release grabs the attention of your target audience and doesn’t let go. While our competitors look to nickel and dime you with hidden fees and restrictive word limits, InvestorWire keeps things transparent. We offer UNLIMITED Words on all domestic releases. While other wire services may provide a basic review of your release, InvestorWire helps you put your best foot forward with complimentary Press Release Enhancement.

With our competitors, the work is done the second your release crosses the wire. Not with InvestorWire. We include follow-up coverage of every release by leveraging the ever-expanding audiences of the 50+ brands that make up the InvestorBrandNetwork.

Get more out of your next press release with InvestorWire. It’s unlike anything you’ve seen before.

For more information, please visit https://www.investorwire.com

Please see full terms of use and disclaimers on the InvestorBrandNetwork website applicable to all content provided by IBN, wherever published or re-published: http://ibn.fm/Disclaimer

InvestorWire (IW)
8033 Sunset Blvd Suite 1037-IW
Los Angeles, CA 90046
310.299.1717 Office
www.investorwire.com
[email protected]

InvestorWire is part of the InvestorBrandNetwork.

Get Started with InvestorWire

To distribute a release in the next 24 hours. Contact our client services team.

(862) 930-1404

Distribute a press release. Submit your release to get started.

Submit Press Release

Set up a Live demonstration. Schedule a date and time that works for you.

Schedule a LIVE Demo

Press Distribution

Explore Press Distribution Solutions

All releases include an unlimited word count* with full wire-grade syndication, our press release enhancement service, and a follow-up InvestorNewsBreak article distributed to thousands of editorial syndication partners.

Discover Add-on Solutions

Increase the impact of your achievements by adding these exclusive solutions from InvestorWire, delivered in conjunction with the InvestorBrandNetwork (IBN).